{
    "root": "30c83e01-beaa-6c18-e063-6394a90a01fe",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Citalopram",
    "value": "20250320",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "HYPROMELLOSE 2910 (3 MPA.S)",
            "code": "0VUT3PMY82"
        },
        {
            "name": "HYPROMELLOSE 2910 (6 MPA.S)",
            "code": "0WZ8WG20P6"
        },
        {
            "name": "HYPROMELLOSE 2910 (50 MPA.S)",
            "code": "1IVH67816N"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POLYDEXTROSE",
            "code": "VH2XOU12IE"
        },
        {
            "name": "POLYETHYLENE GLYCOL 8000",
            "code": "Q662QK8M3B"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673"
        },
        {
            "name": "CITALOPRAM HYDROBROMIDE",
            "code": "I1E9D14F36"
        }
    ],
    "indications": "Citalopram tablets are indicated for the treatment of major depressive disorder (MDD) in adults\n \n  [see\n  \n   Clinical Studies (14)]\n \n  .",
    "contraindications": "Administer once daily with or without food ( 2 ) . Initial dosage is 20 mg once daily; after one week may increase to maximum dosage of 40 mg once daily ( 2.1 ) . Patients greater than 60 years of age, patients with hepatic impairment, and CYP2C19 poor metabolizers: maximum recommended dosage is 20 mg once daily ( 2.2 ) . When discontinuing citalopram tablets, reduce dosage gradually ( 2.4 , 5.6 ) .",
    "warningsAndPrecautions": "Citalopram Tablets, USP are available containing citalopram hydrobromide, USP equivalent to 40 mg citalopram.\n                  The 40 mg tablets are white, film-coated, round, scored tablets debossed with MX33 on one side of the tablet and a score line on the other side. They are available as follows:\n                  \n                  NDC: 70518-2601-00\n                  NDC: 70518-2601-01\n                  NDC: 70518-2601-02\n                  NDC: 70518-2601-03\n                  PACKAGING: 90 in 1 BOTTLE PLASTIC\n                  PACKAGING: 100 in 1 BOX\n                  PACKAGING: 1 in 1 POUCH\n                  PACKAGING: 30 in 1 BLISTER PACK\n                  \n                  Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature.]\n                  Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.\n                  PHARMACIST: Dispense a Medication Guide with each prescription.\n                  \n                  Repackaged and Distributed By:\n                  Remedy Repack, Inc.\n                  625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762",
    "adverseReactions": "Citalopram tablets are contraindicated in patients:\n                  \n                     taking, or within 14 days of stopping, MAOIs (including MAOIs such as linezolid or intravenous methylene blue) because of an increased risk of serotonin syndrome\n  \n   [see\n   \n    Warnings and Precautions (5.3),\n   \n    Drug Interactions (7)]\n  \n   .\n \n  \n                     taking pimozide because of risk of QT prolongation\n  \n   [see\n   \n    Drug Interactions (7)]\n  \n   .\n \n  \n                     with known hypersensitivity to citalopram or any of the inactive ingredients in citalopram tablets. Reactions have included angioedema and anaphylaxis\n  \n   [see\n   \n    Adverse Reactions (6.2)]\n  \n   ."
}